|
| |
| | | 69080 | | 23.08.2023 | | AstraZeneca AG | | | | | | | 22.08.2028 | | | | | | 03.04.50. | | | | 03.04.50. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Tezspire 110 mg/ml | Injektionslösung in einem Fertigpen | Injektionslösung in einem Fertigpen (Tezepelumabum 210 mg) | R03DX11 | CI |
|
|
|